A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure

Clinical trial NCT06299826 · COMPLETED

Trial details

NCT number: NCT06299826
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Heart Failure

Start date: 2024-06-04
Primary completion: 2026-02-10
Enrollment: 375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.